Evaluation of Vancomycin Prediction Methods Based on Estimated Creatinine Clearance or Trough Levels

Area of Science:

• Pharmacology
• Clinical Pharmacy
• Pharmacokinetics

Background:

• Vancomycin is a critical antibiotic for treating serious Gram-positive infections.
• Accurate dosing of vancomycin is essential to maximize efficacy and minimize toxicity.
• Current prediction methods for vancomycin clearance (CLva) may not be sufficiently accurate.

Purpose of the Study:

• To evaluate the predictive accuracy of existing vancomycin clearance (CLva) estimation methods.
• To identify other patient-specific factors (covariates) that influence CLva.
• To assess the reliability of using trough vancomycin levels to predict 24-hour area under the curve (AUC24).

Main Methods:

• Vancomycin plasma levels were measured using fluorescence polarization immunoassay.
• Individual patient pharmacokinetic parameters, including CLva, were determined using Bayesian estimation.
• Three CLva prediction methods based on creatinine clearance (CLcr) were compared against Bayesian estimates; prediction errors were calculated.
• Correlations between CLva and various covariates (CLcr, creatinine, age, weight, sex, neutropenia) were analyzed.
• Correlation between trough vancomycin levels and AUC24 was evaluated.

Main Results:

• Prediction errors for the three CLva methods ranged from 28% to 80%, with absolute errors from 39% to 83%.
• Multivariate analysis revealed significant associations between CLva and CLcr, creatinine, age, weight, sex, and neutropenia.
• The linear correlation between AUC24 and trough levels was weak (R² = 0.38).

Conclusions:

• CLva prediction algorithms relying solely on estimated CLcr exhibit substantial prediction errors, rendering them unreliable for clinical application.
• Factors beyond creatinine clearance significantly impact individual vancomycin clearance.
• Trough vancomycin levels demonstrate a low correlation with AUC24, precluding their use for predicting 24-hour exposure.
• Therapeutic drug monitoring is essential for achieving reliable, AUC24-guided vancomycin dosing.